Skip to content
10-Q/A

Quarterly Report

NUTEX HEALTH INC. NUTX

0001628280-25-052951

← back to feed
Filed
Nov 18, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding restated Q1 2025 · May 12, 2025 5.99M sh
Shares Diluted restated Q1 2025 · Mar 31, 2025 6.45M sh
Shares Diluted Q1 2025 · Mar 31, 2024 4.85M sh
Capex Q1 2025 · Mar 31, 2025 $64K
Capex Q1 2025 · Mar 31, 2024 $733K
Operating Cash Flow Q1 2025 · Mar 31, 2025 $50.97M
Operating Cash Flow restated Q1 2025 · Mar 31, 2024 $3.05M
Long Term Debt Q1 2025 · Mar 31, 2025 $21.73M
Long Term Debt Q1 2025 · Dec 31, 2024 $22.47M
Cash And Equivalents restated Q1 2025 · Mar 31, 2025 $84.73M
Cash And Equivalents restated Q1 2025 · Dec 31, 2024 $40.64M
Stockholders Equity restated Q1 2025 · Mar 31, 2025 $176.95M
Stockholders Equity restated Q1 2025 · Dec 31, 2024 $132.44M
Current Liabilities restated Q1 2025 · Mar 31, 2025 $196.18M
Current Liabilities restated Q1 2025 · Dec 31, 2024 $154.23M
Total Liabilities restated Q1 2025 · Mar 31, 2025 $506.65M
Total Liabilities restated Q1 2025 · Dec 31, 2024 $466.79M
Current Assets Q1 2025 · Mar 31, 2025 $401.52M
Current Assets restated Q1 2025 · Dec 31, 2024 $292.48M
Total Assets Q1 2025 · Mar 31, 2025 $761.92M
Total Assets restated Q1 2025 · Dec 31, 2024 $655.32M
Eps Diluted restated Q1 2025 · Mar 31, 2025 $3.33
Eps Diluted restated Q1 2025 · Mar 31, 2024 −$0.08
Eps Basic restated Q1 2025 · Mar 31, 2025 $3.74
Eps Basic restated Q1 2025 · Mar 31, 2024 −$0.08
Sga Expense Q1 2025 · Mar 31, 2025 $10.04M
Sga Expense restated Q1 2025 · Mar 31, 2024 $8.66M
Net Income restated Q1 2025 · Mar 31, 2025 $21.22M
Net Income restated Q1 2025 · Mar 31, 2024 −$364K
Operating Income restated Q1 2025 · Mar 31, 2025 $80.66M
Operating Income restated Q1 2025 · Mar 31, 2024 $1.45M
Gross Profit Q1 2025 · Mar 31, 2025 $118.34M
Gross Profit restated Q1 2025 · Mar 31, 2024 $10.16M